TITLE

Out of step on AIDS

PUB. DATE
June 1991
SOURCE
New Scientist;6/29/91, Vol. 130 Issue 1775, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the inequalities between industrialized and developing countries in managing AIDS. Inability of developing to gain access to antiviral drug zidovudine; Claim that HIV infection is difficult to transmit and relatively stoppable; Failure of biotechnology companies to provide low-cost AIDS drugs for developing countries.
ACCESSION #
10491301

 

Related Articles

  • The Spirit of TRIPS and the Importation of Medicines Made under Compulsory License after the August 2003 TRIPS Council Agreement. Fayerman, Jessica J. // Northwestern Journal of International Law & Business;Fall2004, Vol. 25 Issue 1, p257 

    Focuses on the issue concerning the harmonization of pharmaceutical laws since the drafting of the Agreement on Trade-Related Aspects of Intellectual Property Rights in developing countries. Importance of the uniform world intellectual property laws for the promotion of free and balanced trade...

  • Glaxo cuts drug prices for developing countries. Wise, Jacqui // BMJ: British Medical Journal (International Edition);06/23/2001, Vol. 322 Issue 7301, p1510 

    Reports that the pharmaceutical company GlaxoSmithKline will lower the cost of its antimalarial and newer HIV and AIDS drugs to developing countries. Details of the announcement, including which countries will be eligible; Response by the World Health Organization (WHO) and aid charities;...

  • Cut-Rate AIDS. Golden, Frederic // Time International (South Pacific Edition);3/19/2001, Issue 11, p56 

    Reports on the need for lower prices for combination-drug therapy for AIDS disease in developing countries. Efforts of pharmaceutical companies to avoid cutting prices and keeping generic copies of their drugs out of South Africa; Decision of Merck and other drug companies to cut prices for...

  • Cut-Rate AIDS. Golden, Frederic // Time;3/19/2001, Vol. 157 Issue 11, p68 

    Reports on the need for lower prices for combination-drug therapy for AIDS disease in developing countries. Efforts of pharmaceutical companies to avoid cutting prices and keeping generic copies of their drugs out of South Africa; Decision of Merck and other drug companies to cut prices for...

  • Recent Publications, Information and Events.  // WHO Drug Information;2006, Vol. 20 Issue 3, p200 

    This article focuses on the health publications, information, and events worldwide. The publications are presented including "Untangling the Web of Price Reductions: a Pricing Guide for the Purchase of ARVs for Developing Countries" by Medicins Sans Frontieres (MSF) in October 2001, "From Access...

  • THE SEARCH FOR NEW GLOBAL HEALTH ENTREPRENEURS. Kettler, Hannah E. // Nature Reviews Drug Discovery;Nov2003, Vol. 2 Issue 11, p931 

    Focuses on the establishment of public-private partnerships (PPPs) that are explicitly focused on the need for, and supply of, new tools and drugs to fight global infectious `diseases of poverty.' Observation that separate PPPs already work on malaria drugs, tuberculosis (TB) drugs, malaria...

  • Despite Doha Declaration, drug costs too high in developing world.  // Nation's Health;Dec2006/Jan2007, Vol. 36 Issue 10, p23 

    The article reports on the high costs of drugs in developing countries. After five years of the Doha Declaration, Oxfam International said wealthier nations are taking little or no action toward their promises of low-cost medications. The declaration states that developing countries must be able...

  • People power: Water and sanitation in third world development. Belasco, D.B. // Africa Today;1990 3rd Quarter, Vol. 37 Issue 3, p81 

    Video review. Reviews the three-part series of films `Water Supply and Sanitation in Development,' including the films: `People and Problems,' `Problems and Solutions,' and `Solutions and People,' produced by the National Film Board of Canada.

  • DEVELOPING WORLD SUCCEEDING AGAINST DISEASES.  // African Business;Feb2001, Issue 262, p15 

    Presents key findings of the report 'Health, a Key to Prosperity: Success Stories in Developing Countries,' which outlined key factors for combating diseases in developing countries. Strategies to fight diseases that perpetuate poverty; Prospects for intervening to prevent death in developing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics